The Standard's journalism is supported by our readers. When you purchase through links on our site, we may earn an affiliate commission. Tired, hot and sore: do these sound like your eyes after a ...

The product is bioequivalent to Pataday Once Daily Relief Ophthalmic Solution, 0.2% (OTC), developed by Alcon Laboratories, Inc. This approval would allow Glenmark Therapeutics Inc., USA to ...

Although pink eye typically resolves naturally, eye drops can expedite recovery and ease symptoms. In this article, we will explore the top-rated eye drops for managing conjunctivitis. When it ...

Olopatadine ophthalmic (eye) drops are used to treat itching of the eye caused by a condition known as allergic conjunctivitis (pink eye). This medicine is also used to treat eye itching or redness ...

Glenmark Pharmaceuticals Inc., USA (Glenmark), a research-led, global pharmaceutical company, has received final approval by the United States Food & Drug Administration (FDA) for olopatadine ...

Glenmark Pharmaceuticals Ltd on Thursday (March 20) said its arms Pharmaceuticals Inc., USA, has received final approval from the US Food & Drug Administration (USFDA) for its Olopatadine ...

(RTTNews) - Glenmark Pharmaceuticals Inc., USA announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its Olopatadine Hydrochloride Ophthalmic Solution ...

1 Glenmark's Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) is only marketed for the indications listed in Glenmark's approved drug facts label. 2 This product is not manufactured ...

You can follow us on LinkedIn (Glenmark Pharmaceuticals) and Instagram (glenmark_pharma). 1 Glenmark's Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) is only marketed for the ...